214 related articles for article (PubMed ID: 16158059)
21. Drosophila abelson interacting protein (dAbi) is a positive regulator of abelson tyrosine kinase activity.
Juang JL; Hoffmann FM
Oncogene; 1999 Sep; 18(37):5138-47. PubMed ID: 10498863
[TBL] [Abstract][Full Text] [Related]
22. Intrinsic regulation of the interactions between the SH3 domain of p85 subunit of phosphatidylinositol-3 kinase and the protein network of BCR/ABL oncogenic tyrosine kinase.
Ren SY; Xue F; Feng J; Skorski T
Exp Hematol; 2005 Oct; 33(10):1222-8. PubMed ID: 16219545
[TBL] [Abstract][Full Text] [Related]
23. Modelling of the ABL and ARG proteins predicts two functionally critical regions that are natively unfolded.
Buffa P; Manzella L; Consoli ML; Messina A; Vigneri P
Proteins; 2007 Apr; 67(1):1-11. PubMed ID: 17211892
[TBL] [Abstract][Full Text] [Related]
24. Iterative tyrosine phosphorylation controls non-canonical domain utilization in Crk.
Sriram G; Jankowski W; Kasikara C; Reichman C; Saleh T; Nguyen KQ; Li J; Hornbeck P; Machida K; Liu T; Li H; Kalodimos CG; Birge RB
Oncogene; 2015 Aug; 34(32):4260-9. PubMed ID: 25381819
[TBL] [Abstract][Full Text] [Related]
25. Mutation of a phenylalanine conserved in SH3-containing tyrosine kinases activates the transforming ability of c-Abl.
Jackson PK; Paskind M; Baltimore D
Oncogene; 1993 Jul; 8(7):1943-56. PubMed ID: 8510937
[TBL] [Abstract][Full Text] [Related]
26. C-terminal SH3 domain of CrkII regulates the assembly and function of the DOCK180/ELMO Rac-GEF.
Akakura S; Kar B; Singh S; Cho L; Tibrewal N; Sanokawa-Akakura R; Reichman C; Ravichandran KS; Birge RB
J Cell Physiol; 2005 Jul; 204(1):344-51. PubMed ID: 15700267
[TBL] [Abstract][Full Text] [Related]
27. The crystal structure of a c-Src complex in an active conformation suggests possible steps in c-Src activation.
Cowan-Jacob SW; Fendrich G; Manley PW; Jahnke W; Fabbro D; Liebetanz J; Meyer T
Structure; 2005 Jun; 13(6):861-71. PubMed ID: 15939018
[TBL] [Abstract][Full Text] [Related]
28. The identification of conserved interactions within the SH3 domain by alignment of sequences and structures.
Larson SM; Davidson AR
Protein Sci; 2000 Nov; 9(11):2170-80. PubMed ID: 11152127
[TBL] [Abstract][Full Text] [Related]
29. The Abl SH2-kinase linker naturally adopts a conformation competent for SH3 domain binding.
Chen S; Brier S; Smithgall TE; Engen JR
Protein Sci; 2007 Apr; 16(4):572-81. PubMed ID: 17327393
[TBL] [Abstract][Full Text] [Related]
30. Mutant mice lacking Crk-II caused by the gene trap insertional mutagenesis: Crk-II is not essential for embryonic development.
Imaizumi T; Araki K; Miura K; Araki M; Suzuki M; Terasaki H; Yamamura K
Biochem Biophys Res Commun; 1999 Dec; 266(2):569-74. PubMed ID: 10600543
[TBL] [Abstract][Full Text] [Related]
31. A potential SH3 domain-binding site in the Crk SH2 domain.
Anafi M; Rosen MK; Gish GD; Kay LE; Pawson T
J Biol Chem; 1996 Aug; 271(35):21365-74. PubMed ID: 8702917
[TBL] [Abstract][Full Text] [Related]
32. Mutagenesis of a buried polar interaction in an SH3 domain: sequence conservation provides the best prediction of stability effects.
Maxwell KL; Davidson AR
Biochemistry; 1998 Nov; 37(46):16172-82. PubMed ID: 9819209
[TBL] [Abstract][Full Text] [Related]
33. A miniprotein scaffold used to assemble the polyproline II binding epitope recognized by SH3 domains.
Cobos ES; Pisabarro MT; Vega MC; Lacroix E; Serrano L; Ruiz-Sanz J; Martinez JC
J Mol Biol; 2004 Sep; 342(1):355-65. PubMed ID: 15313630
[TBL] [Abstract][Full Text] [Related]
34. Crk family adaptor proteins trans-activate c-Abl kinase.
Shishido T; Akagi T; Chalmers A; Maeda M; Terada T; Georgescu MM; Hanafusa H
Genes Cells; 2001 May; 6(5):431-40. PubMed ID: 11380621
[TBL] [Abstract][Full Text] [Related]
35. Distinct ligand preferences of Src homology 3 domains from Src, Yes, Abl, Cortactin, p53bp2, PLCgamma, Crk, and Grb2.
Sparks AB; Rider JE; Hoffman NG; Fowlkes DM; Quillam LA; Kay BK
Proc Natl Acad Sci U S A; 1996 Feb; 93(4):1540-4. PubMed ID: 8643668
[TBL] [Abstract][Full Text] [Related]
36. Cytoplasmic c-Abl provides a molecular 'Rheostat' controlling carcinoma cell survival and invasion.
Kain KH; Gooch S; Klemke RL
Oncogene; 2003 Sep; 22(38):6071-80. PubMed ID: 12955086
[TBL] [Abstract][Full Text] [Related]
37. Discovery and characterization of a cell-permeable, small-molecule c-Abl kinase activator that binds to the myristoyl binding site.
Yang J; Campobasso N; Biju MP; Fisher K; Pan XQ; Cottom J; Galbraith S; Ho T; Zhang H; Hong X; Ward P; Hofmann G; Siegfried B; Zappacosta F; Washio Y; Cao P; Qu J; Bertrand S; Wang DY; Head MS; Li H; Moores S; Lai Z; Johanson K; Burton G; Erickson-Miller C; Simpson G; Tummino P; Copeland RA; Oliff A
Chem Biol; 2011 Feb; 18(2):177-86. PubMed ID: 21338916
[TBL] [Abstract][Full Text] [Related]
38. Crk family adaptors-signalling complex formation and biological roles.
Feller SM
Oncogene; 2001 Oct; 20(44):6348-71. PubMed ID: 11607838
[TBL] [Abstract][Full Text] [Related]
39. A molecular mechanism for autoinhibition of the tandem SH3 domains of p47phox, the regulatory subunit of the phagocyte NADPH oxidase.
Yuzawa S; Suzuki NN; Fujioka Y; Ogura K; Sumimoto H; Inagaki F
Genes Cells; 2004 May; 9(5):443-56. PubMed ID: 15147273
[TBL] [Abstract][Full Text] [Related]
40. Structural basis of the differential binding of the SH3 domains of Grb2 adaptor to the guanine nucleotide exchange factor Sos1.
McDonald CB; Seldeen KL; Deegan BJ; Farooq A
Arch Biochem Biophys; 2008 Nov; 479(1):52-62. PubMed ID: 18778683
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]